• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医院使用抑酸药物及其对全科医疗处方的影响:一项为期1个月的调查。

Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: a 1-month survey.

作者信息

Parente F, Cucino C, Gallus S, Bargiggia S, Greco S, Pastore L, Bianchi Porro G

机构信息

Department of Gastroenterology, L. Sacco University Hospital, Milan, Italy.

出版信息

Aliment Pharmacol Ther. 2003 Jun 15;17(12):1503-6. doi: 10.1046/j.1365-2036.2003.01600.x.

DOI:10.1046/j.1365-2036.2003.01600.x
PMID:12823152
Abstract

BACKGROUND

Acid-suppressive medications are commonly used in hospitalized patients, but, to date, little is known about the overall use of these drugs in the hospital setting.

AIM

To evaluate the appropriateness of acid-suppressive therapy in a large teaching hospital in northern Italy, and the fall-out of hospital prescription in general practice.

METHODS

The use of antisecretory agents was monitored for 1 month in adult patients consecutively admitted to L. Sacco University Hospital by reviewing their clinical charts. The appropriateness of each prescription was reviewed jointly by two consultant gastroenterologists.

RESULTS

A total of 46.8% of 799 hospitalized patients received acid-suppressive therapy. Ranitidine was the most frequently used drug (44.4%), followed by pantoprazole (31.8%) and omeprazole (23.0%). Stress ulcer prophylaxis and the prevention of non-steroidal anti-inflammatory drug-induced ulcer accounted for 60.4% of the indications for use. Overall, 68% of prescriptions were not appropriate as determined by consensus review; 56.4% of patients receiving unnecessary prophylactic treatment whilst in hospital were discharged on therapy, and 46% were still receiving the treatment 3 months later.

CONCLUSIONS

Acid-suppressive agents are over-used in hospitalized patients. Most of the inappropriate hospital prescriptions are for ulcer prophylaxis in low-risk patients. This unnecessary use may also induce inappropriate drug consumption in general practice.

摘要

背景

抑酸药物在住院患者中普遍使用,但迄今为止,对于这些药物在医院环境中的整体使用情况知之甚少。

目的

评估意大利北部一家大型教学医院中抑酸治疗的合理性,以及医院处方在全科医疗中的后续影响。

方法

通过查阅临床病历,对连续入住L. Sacco大学医院的成年患者使用抗分泌药物的情况进行了1个月的监测。每份处方的合理性由两位胃肠病学顾问共同审查。

结果

799名住院患者中,共有46.8%接受了抑酸治疗。雷尼替丁是最常用的药物(44.4%),其次是泮托拉唑(31.8%)和奥美拉唑(23.0%)。应激性溃疡预防和非甾体抗炎药所致溃疡的预防占用药指征的60.4%。总体而言,经共识审查确定,68%的处方不合理;6.4%接受不必要预防性治疗的住院患者出院时仍在接受治疗,46%的患者在3个月后仍在接受治疗。

结论

住院患者中抑酸药物使用过度。大多数不合理的医院处方是用于低风险患者的溃疡预防。这种不必要的使用还可能导致全科医疗中药物的不当消费。

相似文献

1
Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: a 1-month survey.医院使用抑酸药物及其对全科医疗处方的影响:一项为期1个月的调查。
Aliment Pharmacol Ther. 2003 Jun 15;17(12):1503-6. doi: 10.1046/j.1365-2036.2003.01600.x.
2
Helicobacter pylori and dyspepsia: physicians' attitudes, clinical practice, and prescribing habits.幽门螺杆菌与消化不良:医生的态度、临床实践及处方习惯
Aliment Pharmacol Ther. 2002 Mar;16(3):487-96. doi: 10.1046/j.1365-2036.2002.01183.x.
3
Overuse of acid-suppressive therapy in hospitalized patients.住院患者抑酸治疗的过度使用。
Am J Gastroenterol. 2000 Nov;95(11):3118-22. doi: 10.1111/j.1572-0241.2000.03259.x.
4
Do recent reports about the adverse effects of proton pump inhibitors change providers' prescription practice?近期有关质子泵抑制剂不良反应的报道是否改变了医疗服务提供者的处方习惯?
Dis Esophagus. 2018 Dec 1;31(12). doi: 10.1093/dote/doy042.
5
[Use of acid-suppressive medications in hospitalized patients].[住院患者中抑酸药物的使用情况]
An Med Interna. 2002 Nov;19(11):557-60.
6
Inadequate use of acid-suppressive therapy in hospitalized patients and its implications for general practice.住院患者抑酸治疗的使用不足及其对全科医疗的影响。
Dig Dis Sci. 2005 Dec;50(12):2307-11. doi: 10.1007/s10620-005-3052-4.
7
Prescribing of proton pump inhibitors for gastrointestinal bleeding prophylaxis in the Lebanese outpatient setting: patterns, compliance with guidelines and risks.黎巴嫩门诊环境中用于预防胃肠道出血的质子泵抑制剂的处方:模式、指南遵循情况及风险
Int J Pharm Pract. 2019 Aug;27(4):386-392. doi: 10.1111/ijpp.12537. Epub 2019 Apr 3.
8
A questionnaire on prescription patterns of proton pump inhibitors for hemodialysis patients in Japan.日本血液透析患者质子泵抑制剂处方模式调查问卷。
Clin Exp Nephrol. 2020 Jun;24(6):565-572. doi: 10.1007/s10157-020-01866-z. Epub 2020 Mar 8.
9
Inappropriate utilization of intravenous proton pump inhibitors in hospital practice--a prospective study of the extent of the problem and predictive factors.静脉质子泵抑制剂在医院实践中的不适当应用——问题程度和预测因素的前瞻性研究。
QJM. 2010 May;103(5):327-35. doi: 10.1093/qjmed/hcq019. Epub 2010 Mar 7.
10
[Evaluation of the prescription of proton pump inhibitors in persons aged 75years and older in a geriatric acute-care unit].[老年急性护理病房中75岁及以上老年人质子泵抑制剂处方的评估]
Therapie. 2017 Dec;72(6):669-675. doi: 10.1016/j.therap.2017.06.003. Epub 2017 Jul 29.

引用本文的文献

1
Appropriate Use of Proton Pump Inhibitors in General Out Patient Department of a Tertiary Care Center of Kathmandu Valley: An Observational Study.加德满都谷地一家三级护理中心普通门诊部质子泵抑制剂的合理使用:一项观察性研究
JNMA J Nepal Med Assoc. 2025 Mar;63(283):149-153. doi: 10.31729/jnma.8913. Epub 2025 Mar 31.
2
Optimizing stress ulcer prophylaxis practices and reducing associated costs in intensive care units: a non-randomized controlled study.优化重症监护病房应激性溃疡预防措施并降低相关成本:一项非随机对照研究。
J Pharm Pharm Sci. 2025 Apr 10;28:14295. doi: 10.3389/jpps.2025.14295. eCollection 2025.
3
Ensuring guideline adherence and cost savings in stress ulcer prophylaxis practices in the intensive care unit: a pre-post education study.
确保重症监护病房应激性溃疡预防措施符合指南要求并节省成本:一项教育前后对照研究。
J Pharm Pharm Sci. 2025 Mar 4;28:14067. doi: 10.3389/jpps.2025.14067. eCollection 2025.
4
Efficacy of a computer based discontinuation strategy to reduce PPI prescriptions: a multicenter cluster-randomized controlled trial.基于计算机的停药策略降低 PPI 处方的疗效:一项多中心整群随机对照试验。
Sci Rep. 2023 Dec 7;13(1):21633. doi: 10.1038/s41598-023-48839-2.
5
Are Proton Pump Inhibitors Contributing in Emerging New Hypertensive Population?质子泵抑制剂是否与新出现的高血压人群有关?
Pharmaceuticals (Basel). 2023 Sep 30;16(10):1387. doi: 10.3390/ph16101387.
6
Appropriateness of proton pump inhibitors use in noncritically ill hospitalized children in a tertiary hospital in Saudi Arabia.沙特阿拉伯一家三级医院非危重症住院儿童使用质子泵抑制剂的合理性。
Saudi Pharm J. 2023 Sep;31(9):101723. doi: 10.1016/j.jsps.2023.101723. Epub 2023 Jul 31.
7
Association of Proton Pump Inhibitor Prophylaxis on Clinical Outcome in Acute Ischemic Stroke in China: A Multicenter Retrospective Cohort Study.中国质子泵抑制剂预防对急性缺血性卒中临床结局的影响:一项多中心回顾性队列研究
J Clin Med. 2022 Nov 22;11(23):6881. doi: 10.3390/jcm11236881.
8
Pharmacist-structured review of proton pump inhibitor utilisation in primary care: A nonrandomised control study.药剂师对基层医疗中质子泵抑制剂使用情况的结构化审查:一项非随机对照研究。
Malays Fam Physician. 2021 Oct 3;16(3):87-96. doi: 10.51866/oa1153. eCollection 2021 Nov 30.
9
Current Practice of Stress Ulcer Prophylaxis in Surgical Departments in Mecklenburg Western Pomerania, Germany.德国梅克伦堡-前波美拉尼亚州外科应激性溃疡预防的当前实践。
Healthcare (Basel). 2021 Nov 2;9(11):1490. doi: 10.3390/healthcare9111490.
10
Interactions between epidermal growth factor receptor tyrosine kinase inhibitors and proton-pump inhibitors/histamine type-2 receptor antagonists in non-small cell lung cancer: a systematic review and meta-analysis.表皮生长因子受体酪氨酸激酶抑制剂与质子泵抑制剂/组胺2型受体拮抗剂在非小细胞肺癌中的相互作用:一项系统评价和荟萃分析。
Transl Lung Cancer Res. 2021 Aug;10(8):3567-3581. doi: 10.21037/tlcr-21-378.